Longbio-b

1779.HK

HKSEHealthcareBiotechnology

Open in GoAI

Latest quote

HK$117.9

+HK$3.00 · +2.61%

Aug 24, 4:08 PM HKT

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Longbio Pharma (Suzhou) Co., Ltd. operates as a clinical-stage biotechnology company. It focuses on in-house discovery and development of biopharmaceuticals targeting on allergic and autoimmune diseases. The company was founded by Heng Liu and Nai-Chau Sun on October 26, 2020 and is headquartered Suzhou, China.

Industry: Biotechnology
Sector: Healthcare
Headquarters: CN
CEO: Heng Liu
Listed since: Jun 5, 2026
Employees: 85